AhR, aryl hydrocarbon receptor; C/EBP, CCAAT/enhancer-binding protein; COX-1, cyclooxygenase-1; COX-2, cyclooxygenase-2; CREB, cAMP response element-binding protein;
Site-Directed MutagenesisMutant COX-2 promoter constructs were made using QuikChange II Site-Directed Mutagenesis kit (Stratagene, Inc., La Jolla, CA) according to the manufacturer's instruction. Construct pCOX2 (-371/+70) was used as a template for the other constructs. Mutant constructs were named by transcription factors. The consensus binding site of each transcription factor was mutated as shown in Table 1 and 2. The underlined nucleotides indicate the mutations. All the mutations were confirmed by direct DNA sequencing.
Transient Transfection and Luciferase AssaysThe day before transfection, RINm5F
cells were plated into six-well tissue culture plates at a density of 5 X 10 5 cells per well.
Transfections were performed using SuperFect reagent (Qiagen), following the manufacturer's protocol. Each transfection was performed using 1.5 µg of Firefly luciferase reporter construct DNA that contained various deletions and site-directed mutants of COX-2 promoter gene plus 0.1 µg of an internal control Renilla luciferase reporter plasmid pRL-TK (Promega Inc., Madison, WI). Two and one half hours after transfection, the medium was removed by aspiration and replaced with normal culture media containing 10% FBS and antibiotics. Following an overnight recovery period, the transfected cells were cultured in medium with 0.2% BSA for 48 hours. All treatments were performed in 0.2% BSA medium 24 hours before cells were collected. Cell extracts were prepared for luciferase determination according to the protocol accompanying the Dual-Luciferase Reporter Assay System (Promega). Firefly and Renilla luciferase activities
were measured with a TD-20/20 luminometer (Turner Designs, Inc., Sunnyvale, CA). Firefly luciferase activity was normalized to Renilla luciferase activity. Each experiment was performed in triplicate and repeated two or three times independently.
RNA Preparation and Relative RT-PCR1 x 10
6 RINm5F cells were seeded in 60 mm culture dishes. On the next day, the cells were switched to 0.2% BSA medium for 24 hours.
Cells were changed to fresh 0.2% BSA medium and different concentrations of forskolin or TCDD were added. Fours hours later, the cells were collected and total RNA was isolated with Nuclear Extracts3 X 10 6 RINm5F cells were seeded in 100 mm dishes in triplicate.
Next day, the cells were switched to 0.2% BSA medium for 48 hours to maintain the same culturing condition as the transfected cells used for luciferase assays. Cells were washed once with PBS and scraped in PBS. Then, the cells were centrifuged for 3 min at 3000 RPM and the pellet suspended in 300 µl NP 40 lysis buffer (10 mM Tris, pH 7.5; 10 mM NaCl; 3 mM MgCl 2 ;
0.5% NP 40). After centrifugation, the pellet was treated with 50 µl low salt buffer (20 mM NaCl, 1 mM EDTA, 20% glycerol, 20 mM HEPES, pH 7.9) and 50 µl high salt buffer (1 M NaCl, 1 mM EDTA, 20% glycerol, 20 mM HEPES, pH 7.9) with vortexing in a cold room. The mixture was rotated at 4 o C for 30 min followed by the addition of 100 µl low salt buffer. After centrifugation at 15,000 RPM for 15 min, the remaining supernatant was the nuclear extract. Protein concentrations were measured using Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA). Binding reactions were conducted with 16 µg of nuclear protein and 0.4 ng of digoxigeninlabeled probe following the manufacturer's protocol. Binding complexes were separated on a 6% DNA retardation gel running at 75 V for one and half hours, after which the gel was transferred to positive-charged nylon membrane by electro-blotting (30 min, 400 mA). The DNA was fixed to membrane by UV cross-link, and chemiluminescent signals were recorded on X-ray film.
Electrophoretic Mobility Shift
StatisticsStudent's t-test was used to evaluate statistical significance of differences between two groups. P < 0.05 was considered statistically significant. and one activation domain (-371/+70 bp) were identified from the results in Fig. 1 those that contained overlapping sequences were WT-1/GR, (NF-κB1/2)/C/EBP, and CREB/Ebox. First, we picked five locations for site-directed mutations. We mutated these five locations separately and determined luciferase activities (Fig. 2) . Compared with the wild type pCOX2(-371/+70), mutation of the NF-1/SP-1 site did not change the promoter activity, while mutation of the WT-1/GR site only decreased promoter activity by thirty percent. In contrast, mutation of the AhR site, the (NF-κB1⁄2)/C/EBP site, or the CREB/E-box site caused major decreases in COX-2 promoter activity by 70%, 74%, and 84%, respectively. Since the AhR site contained no overlapping DNA binding domains, we confirmed that AhR was essential for basal COX-2 expression in β-cells. Since the other two locations contain two transcriptional factors, we performed further studies to determine which factor was essential for COX-2 gene expression.
RESULTS

Analysis of Basal COX-2 Promoter Activity in
CREB and C/EBP, but Not NF-κB 1/2 or E-box, Are Essential for Basal COX-2
Expression In Fig. 2 ., we mutated nucleotides overlapping the NF-κB1⁄2 and C/EBP binding region and the CREB and E-box binding region. Thus, we could not determine which two sites were responsible for COX-2 promoter activation. To solve this problem, we mutated nonoverlapping binding sites in the NF-κB1/2 and C/EBP region and the CREB and E-box region and tested these new promoter constructs. As shown in Table 2 , the mutation sites were carefully selected so that we could discriminate between individual overlapping transcription factor binding sites (eg. NF-κB1/2 and C/EBP binding domains shared bases -93 to -90; therefore, bases -89 and -88 were mutated in the NF-κB1/2 site, while bases -95 and -94
were mutated in the C/EBP site). Using the wild type pCOX2(-371/+70) construct and the four mutant constructs shown in Table 2 , we transiently transfected these reporter constructs into RINm5F cells and determined luciferase activities. As shown in Figure 3 , the NF-κB1⁄2 mutation did not inhibit the reporter activity, while the C/EBP mutation strongly repressed reporter activity by 73% compared to the wild type. Similarly, the E-box mutation slightly decreased reporter gene activity, while the CREB mutation strongly inhibited the promoter activity by 83%. These results indicated that C/EBP and CREB sites were essential for basal COX-2 expression in β-cells.
Synergistic Effect of Mutations in AhR, C/EBP and CREB Sites on COX-2 Promoter
Activity Though single mutation of AhR, C/EBP, or CREB binding site decreased promoter activity by 70-80%, it was unknown whether these sites worked synergistically in regulating the COX-2 promoter. To this end, we designed luciferase reporter constructs containing double mutations of the AhR and C/EBP sites, AhR and CREB sites, C/EBP and CREB sites, and mutation of all three sites. The relative luciferase activities of three double mutant constructs and a triple mutant construct are shown in Figure 4 . Double mutation of AhR and C/EBP sites, or CREB and C/EBP sites did not show synergy, while double mutations of AhR and CREB sites exhibited a further 1.5 to 2-fold reduction in reporter activities compared to single mutations. The triple mutation of AhR, C/EBP, and CREB strongly repressed luciferase activity 2-fold more than the respective single mutation. These results indicated that no synergy existed between AhR and C/EBP sites or CREB and C/EBP, whereas significant synergy was seen between AhR and CREB sites or among all three sites.
Cyclic AMP Activator, Forskolin, Increases COX-2 Promoter Activity and COX-2 mRNA
LevelBased on the observation that mutation of the CREB site inhibited COX-2 promoter activity in β-cells ( Fig. 3 and 4 hours. The transfected cells were treated with forskolin, 4 and 10 µg/ml, and IBMX, 100 and 400 µM, for 24 hours. Forskolin increased luciferase activity 3-fold when compared to untreated cells (Fig. 5) , while IBMX increased luciferase activity 2-fold (data not shown). When the CREB site was mutated, forskolin could not increase the mutant reporter luciferase activity (Fig. 5 ).
We also tested other two constructs, pCOX2(-804/+70) and pCOX2(-907/+70), which contained longer promoter fragment than pCOX2(-371/+70). Even though the -804/+70 bp and -907/+70
bp fragments contained an inhibiting domain, the luciferase activities of pCOX2(-804/+70) and pCOX2(-907/+70) were still increased by the addition of forskolin (10 µg/ml) ( 
TCDD, a Ligand of AhR, Increases COX-2 Promoter Activity via AhR Binding Site in β-
cellsAhR, a basic helix-loop-helix transcription factor, activates genes when bound by environmental contaminants like TCDD and other polychlorinated biphenyl compounds (28).
Since the COX-2 promoter contained an AhR site, we investigated whether TCDD affected COX-2 promoter activity in β-cells. Wild type and AhR mutant constructs of luciferase reporter pCOX2(-371/+70) were transfected to RINm5F cells. After starvation with 0.2% BSA for 24
hours, the cells were treated with 1 nM and 10 nM TCDD for another 24 hours. Then, the relative luciferase activities were determined as shown in Fig. 8 . TCDD increased luciferase activity by ~1.5-fold in wild type pCOX2(-371/+70) promoter construct. Interestingly, TCDD did not increase AhR mutant luciferase reporter activity. Therefore, TCDD increased COX-2 promoter activity via the AhR site. TCDD also increased COX-2 mRNA in a dose-dependent manner using semi-quantitative RT-PCR, as shown in Figure 7B . These results indicated that AhR played a role in both basal and inducible COX-2 gene expression.
Nuclear Factors from RINm5F Cells Specifically Bind the COX-2 Promoter Elements
Containing Immunostaining studies showed that COX-2 is expressed in islet-infiltrating macrophages, and that insulin and COX-2 expression disappeared concomitantly from β-cells when NOD mice progressed toward overt diabetes (30). These results suggested that COX-2 activation might play a pathogenic role in type 1 diabetes. Other studies showing that hyperglycemia induced both IL-1β and COX-2 in human pancreatic β-cells (23,31) provided a link between type 2 diabetes, cytokine-mediated islet dysfunction, and PGE 2 . Thus, it is critical to know how basal and induced COX-2 expression is regulated in β-cells. In this report, we identify an activating domain (-371/+70) through a series of promoter deletions using a 1-kb (-907/+70) mouse COX-2 promoter. Then, by site-directed mutation of putative transcription factor binding sites, we established that the CREB, AhR, and C/EBP binding sites are not only essential for basal COX-2 expression, but also important for induced COX-2 expression. We also studied the synergistic effect of these three binding sites.
In our studies, we observed the highest COX-2 activity when the promoter was deleted to -371 bp. This result is similar to a mouse COX-2 promoter study in NIH 3T3 cells (27) and a human promoter study in human endometrial stromal cells (7) . Therefore, most of the COX-2 promoter activity may come from the proximal 5' flanking region to transcription start site (+1).
In contrast to most other mammalian cell types, islets of Langerhans constitutively express COX-2 more so than COX-1 (22) . To investigate the transcription factors responsible for basal COX-2 activity in β-cells, we use site-directed mutagenesis to mutate putative cis-acting elements as shown in Tables 1 and 2 . We found that mutations in the AhR, CREB and C/EBP binding sites greatly decreased 70 -80% of promoter activity ( Fig. 2 and 3) . However, mutation of SP-1, NF-1, NF-κB 1 and 2 did not affect the basal expression of the COX-2 gene in β-cells.
Mutation of WT-1 and GR sites decreased promoter activity by 30%, while mutation of E-box caused a 20% decrease in promoter activity. Therefore, AhR, CREB, and C/EBP sites were responsible for basal expression of COX-2 gene in β-cells.
Stimulation of adenyl cyclase leads to cAMP generation and subsequent PKA activation.
Thereafter, PKA phosphorylates critical transcription factors like CREB, CREM and ATF1.
These phosphorylated factors can then initiate transcription of target genes. CREB transcription factor has been reported to play a role in regulating basal COX-2 expression in colon carcinoma cells with high basal COX-2 expression (32). CREB has also been shown to be responsible for induced expression of COX-2 gene, such as the induction of COX-2 expression in activated mast cells (12), UVB induction of COX-2 expression in human keratinocytes (33) , and shear stress-induced COX-2 promoter expression in osteoblastic MC3T3-E1 cells (34) . In the murine COX-2 promoter, CREB site (-56/-52) and E-box site (-53/-48) are overlapped. In our study, when the non-overlapped bases of CREB site in the -371/+70 bp region were mutated, the promoter activity was decreased 70% of wild type (Fig. 3) . In contrast, mutation of E-box only caused 20% decrease in promoter activity (Fig. 3 ). E-box sequences, CACGTG, are the binding sites for basic helix-loop-helix (bHLH) transcription factors, such as c-Myc. In mouse skin carcinoma cells, mutation of E-box dramatically decreased basal expression of COX-2 (35).
Thus, the effect of E-box on the murine COX-2 promoter activity is tissue-specific. To investigate the effect of the CREB site on COX-2 promoter activity, we treated RINm5F cells with the cAMP activator, forskolin. Here, COX-2 promoter activity was increased two to three fold by treatment with forskolin (10 µg/ml) ( Fig. 5 and 6 ). Mutation of the CREB site completely abolished the effect of forskolin on promoter activity (Fig. 5) . These results suggested that forskolin increased COX-2 promoter activity via the CREB site. Forskolin also increased the expression of COX-2 mRNA in RINm5F cells in a dose-dependent manner (Fig. 7A ). COX-2 mRNA expression can be upregulated either by increasing the transcription rate (34) (35) (36) or by increasing mRNA stability via highly conserved AU-rich element in 3'-untranslated region (3'-UTR) (37). Thus, further studies will be needed to confirmed whether forskolin increased COX-2 mRNA by increased COX-2 transcription rate or through both increased transcription rate and increased RNA stability. We conclude that the CREB site in COX-2 promoter is not only important for basal expression, but also for induced expression through the cAMP/protein kinase A pathway in pancreatic β-cells. promoter activity was decreased about 70% (Fig. 2) . To identify which factor played the key role in this effect, we mutated the non-overlapped bases of these two sites (Table 2) . Our results (Fig. 3) showed that mutation of the C/EBP site was responsible for the decreased basal COX-2 promoter activity, whereas mutation of the NF-κB 1 and 2 site did not affect basal COX-2 expression. EMSA demonstrated that transcription factors from RINm5F β-cells could specifically bind to the DNA element containing the C/EBP site (Fig 9C) . Since both C/EBPα and C/EBPβ can bind this putative C/EBP site, further experiments will be performed to determine which isoform regulates basal COX-2 expression in β-cells. this study, we identified that the AhR site is required for maintenance of basal COX-2 expression in β-cells (Fig. 2) and TCDD increased the promoter activity via the AhR site (Fig. 8) .
TCDD increased COX-2 mRNA in a dose-dependent manner in RINm5F cells (Fig. 7B) . We also demonstrated that transcription factors from RINm5F cell extracts specifically bound the DNA element containing AhR site by EMSA (Fig. 9A) . These findings are the first to elucidate the effect of AhR transcription factor on COX-2 gene expression in pancreatic β-cells. The biological relevance of AhR-dependent gene activation in pancreatic β-cells has yet to be determined, but we speculate that agents like TCDD may modulate β-cell function through activation of COX-2.
In summary, we identified that AhR, CREB, and C/EBP transcription factors play a 
